论文部分内容阅读
目的分析甲状腺功能亢进症(甲亢)及其治疗与病毒性肝炎的相互影响。方法选择该院治疗的单纯病毒性肝炎患者45例为A组,单纯甲亢患者45例为B组,甲亢合并病毒性肝炎患者45例为C组。比较3组治疗后肝功能、甲状腺功能,分析甲亢及其治疗与病毒性肝炎的互相影响。结果 C组ALT、AST、TB及T3、T4水平均高于A组、B组,ALB水平低于A组、B组(P<0.05)。C组患者采用护肝治疗+抗甲亢治疗的治愈率为93.3%(28/30)高于采用护肝治疗的20.0%(3/15)(P<0.05)。结论甲状腺功能亢进症能够加重病毒性肝炎所造成的肝功能损害,通过抗甲亢治疗能够有效促进甲亢合并病毒性肝炎的肝功能恢复。
Objective To analyze the interaction between hyperthyroidism (Hyperthyroidism) and its treatment and viral hepatitis. Methods Forty-five patients with simple viral hepatitis treated by this hospital were selected as Group A, 45 patients with simple hyperthyroidism as Group B, and 45 patients with hyperthyroidism and viral hepatitis as Group C. Compare the three groups of liver function after treatment, thyroid function, analysis of hyperthyroidism and its treatment and viral hepatitis mutual influence. Results The levels of ALT, AST, TB, T3 and T4 in group C were significantly higher than those in group A, B and ALB, respectively (P <0.05). The cure rate in group C was 93.3% (28/30) with hepatoprotective therapy plus anti-hyperthyroidism compared with 20.0% (3/15) in hepatoprotective therapy (P <0.05). Conclusions Hyperthyroidism can aggravate hepatic dysfunction caused by viral hepatitis, and the anti-hyperthyroidism treatment can effectively promote the recovery of liver function in hyperthyroidism complicated with viral hepatitis.